One of the most consequential factors in your home care agency's valuation is a distinction that many owners do not fully appreciate until they are already in a transaction: whether your agency is classified as non-medical (private duty) or medical (Medicare-certified home health). This single classification affects your EBITDA multiple, the buyer pool interested in your agency, the deal structure you will be offered, and ultimately the total proceeds you walk away with. The gap between the two can be enormous, often 1.5x to 3x in multiple, which translates to hundreds of thousands or millions of dollars in enterprise value.
This guide breaks down the valuation differences between non-medical and medical home care agencies using 2026 transaction data, explains why the gap exists, identifies the hybrid models that are commanding premium multiples, and provides a clear framework for understanding where your agency falls on the spectrum.
Key takeaway: Non-medical home care agencies typically trade at 3.0x to 5.5x Adjusted EBITDA, while Medicare-certified home health agencies command 5.0x to 10.0x or higher. But the story is more nuanced than "medical is better." Your specific payer mix, service lines, geography, and operational maturity matter as much as the medical vs. non-medical label. Understanding these dynamics is essential to positioning your agency for the best possible outcome.
Defining the Two Models: What Buyers See
Before examining valuation differences, it is important to understand how buyers categorize these two agency types. The distinction is not just about services offered. It is about regulatory framework, reimbursement structure, and scalability potential.
| Characteristic | Non-Medical (Private Duty) | Medical (Home Health) |
|---|---|---|
| Primary services | Personal care, companionship, homemaking, ADL assistance | Skilled nursing, PT/OT/ST, wound care, medication management |
| Primary payers | Private pay, Medicaid waiver, long-term care insurance, VA | Medicare, Medicare Advantage, Medicaid, commercial insurance |
| Regulatory oversight | State licensure (varies by state, some states require none) | CMS certification, state licensure, accreditation, OASIS, surveys |
| Workforce | Home health aides, CNAs, companions | RNs, LPNs, PTs, OTs, SLPs, MSWs, HHAs |
| Barriers to entry | Low to moderate (state-dependent) | High (Medicare certification, CON states, accreditation) |
| Revenue per client | $15K-$40K annually (varies by hours) | $3K-$8K per episode (PDGM) |
From a buyer's perspective, these are fundamentally different businesses that happen to serve overlapping patient populations. The valuation methodology is the same, Adjusted EBITDA times a multiple, but the multiples diverge significantly because the risk profiles, growth trajectories, and competitive moats are different.
2026 Valuation Multiples: The Current Data
Based on transaction data from Breakwater M&A, Stoneridge Partners, and industry reports from Mertz Taggart and Capstone Partners, here is where multiples stand in early 2026:
| Agency Type | Revenue Range | EBITDA Multiple | Key Driver |
|---|---|---|---|
| Non-medical (small) | Under $2M | 3.0x-4.0x | Owner dependency, limited scale |
| Non-medical (mid-size) | $2M-$5M | 4.0x-5.5x | Management depth, payer diversification |
| Non-medical (large) | $5M+ | 5.0x-6.5x | Scale, multi-location, Medicaid contracts |
| Medicare home health (small) | Under $5M | 5.0x-7.0x | Medicare certification, star ratings |
| Medicare home health (mid-size) | $5M-$15M | 6.0x-8.5x | Payer mix, clinical outcomes, geography |
| Medicare home health (large/platform) | $15M+ | 8.0x-10.0x+ | Platform potential, multi-state, diversified |
The Stoneridge Partners Acquisition Index (PAI) for home health reached 6.84x as of early 2026, up from 6.42x at the end of 2025, reflecting continued buyer appetite for Medicare-certified agencies. For context, the Enhabit Home Health and Hospice acquisition by Kinderhook Industries closed in February 2026 at an implied multiple of approximately 10x EBITDA, a $1.1 billion transaction that underscores the premium the market places on scaled, Medicare-certified operations.
Why the Gap Exists: Five Structural Reasons
The valuation gap between non-medical and medical home care is not arbitrary. It reflects five structural differences that buyers weigh heavily in their analysis.
1. Barriers to Entry Create Competitive Moats
Medicare certification is a significant barrier. The process takes 12 to 18 months, requires substantial investment in clinical infrastructure, and involves rigorous CMS surveys. In Certificate of Need (CON) states, the barrier is even higher because new Medicare certifications are restricted. When a buyer acquires a Medicare-certified agency, they are buying a license that cannot be easily replicated. Non-medical agencies, by contrast, can be started in many states with minimal licensing requirements, which means the competitive moat is narrower.
2. Medicare Reimbursement Provides Revenue Predictability
Medicare pays on a per-episode basis under the Patient-Driven Groupings Model (PDGM), with rates set by CMS annually. While the CMS 2026 Final Rule included a net 1.3% rate reduction, the overall reimbursement framework is predictable and federally backed. Buyers can model future revenue with reasonable confidence. Non-medical agencies relying on private pay face more revenue volatility because clients can reduce hours, switch providers, or discontinue service at any time.
3. Scalability and Platform Potential
Private equity firms, which now drive the majority of home care M&A activity, are building platforms. A Medicare-certified agency with multi-state operations, established referral networks, and clinical infrastructure is a natural platform candidate. As we detailed in our Platform vs. Add-On analysis, platform acquisitions command 7x to 10x+ multiples because they serve as the foundation for a roll-up strategy. Non-medical agencies can also be platforms, but the path is less common because the service model is simpler and the competitive advantages are harder to sustain.
4. Demographic Tailwinds Favor Both, But Medicare Exposure Wins
The aging population benefits all home-based care providers. But buyers assign a premium to agencies with direct Medicare exposure because Medicare enrollment is growing predictably (10,000 Americans turn 65 every day) and the federal government has signaled a clear preference for home-based care over institutional settings. The CMS expansion of hospital-at-home programs and value-based purchasing initiatives further reinforces this trend.
5. Clinical Outcomes Create Measurable Differentiation
Medicare-certified agencies have star ratings, OASIS data, and clinical outcome metrics that provide objective evidence of quality. Buyers can compare agencies using standardized data. Non-medical agencies lack this standardized quality framework, making it harder for buyers to differentiate between a well-run operation and an average one. This information asymmetry tends to compress multiples for non-medical agencies because buyers apply a risk discount when they cannot objectively verify quality.
The Hybrid Advantage: Agencies That Bridge Both Models
Some of the most attractive acquisition targets in 2026 are agencies that combine non-medical and medical services under one roof. These hybrid models command premium multiples because they offer buyers something neither pure-play model provides alone: the ability to serve patients across the full continuum of home-based care.
| Model | Typical Multiple | Why Buyers Pay More |
|---|---|---|
| Pure non-medical | 3.0x-5.5x | Baseline: personal care services only |
| Pure Medicare home health | 5.0x-10.0x | Medicare certification, clinical infrastructure |
| Hybrid (non-medical + home health) | 6.0x-10.0x+ | Full continuum, cross-referral, patient retention, diversified revenue |
The hybrid premium exists because these agencies can accept a patient referral from a hospital, provide skilled nursing during the acute recovery phase, and then transition the patient to non-medical personal care for ongoing support. This continuity of care reduces patient churn, increases lifetime revenue per patient, and creates natural cross-referral opportunities that pure-play agencies cannot match.
According to Home Health Care News, the trend toward integrated home-based care models is accelerating in 2026, with buyers increasingly seeking agencies that can serve as "one-stop shops" for home-based care needs. This is particularly true for PE platform builders who want to offer the full spectrum of services across their portfolio.
What Non-Medical Agency Owners Can Do to Close the Gap
If you run a non-medical agency and feel discouraged by the multiple gap, there is good news: the gap is not fixed. There are specific, actionable steps you can take to move your agency toward the higher end of the non-medical range or even into hybrid territory.
1. Diversify your payer mix. Agencies with 100% private pay are valued lower than those with a mix of private pay, Medicaid waiver, VA, and long-term care insurance. Each additional payer source reduces revenue concentration risk and increases your multiple. See our Medicaid waiver valuation guide for specifics.
2. Build management depth. The number one valuation driver for non-medical agencies is reducing owner dependency. An agency with a competent operations director, a scheduler who manages the day-to-day, and documented processes will command a materially higher multiple than an owner-operated agency of the same size.
3. Pursue Medicaid waiver contracts. In states with Medicaid waiver programs for home and community-based services (HCBS), these contracts provide recurring, government-backed revenue that buyers value highly. They also demonstrate your agency's ability to navigate government payer requirements, which signals operational maturity.
4. Invest in technology and data. Agencies using modern scheduling software, electronic visit verification (EVV), and data analytics tools are more attractive to buyers. Technology infrastructure signals scalability and reduces integration risk post-acquisition.
5. Consider adding Medicare-certified services. If your market supports it and you have the clinical leadership to execute, adding a Medicare home health line can transform your agency from a non-medical operation into a hybrid model. This is a 12-to-18-month process, but the valuation impact can be dramatic. It is the single highest-ROI investment a non-medical agency owner can make before going to market.
The Medicare Advantage Risk Factor: A 2026 Warning
While Medicare certification generally commands higher multiples, there is an important caveat for 2026: Medicare Advantage (MA) payer concentration is emerging as a significant valuation risk. According to Stoneridge Partners' 2026 outlook, MA plans now account for over 50% of Medicare beneficiaries, and these plans frequently reimburse home health agencies at rates 20% to 40% below traditional Medicare fee-for-service.
Buyers are increasingly scrutinizing the MA vs. traditional Medicare split in home health agencies. An agency with 70% MA payer mix may receive a lower multiple than one with 70% traditional Medicare, even if their total revenue is similar, because the MA revenue is less profitable and more subject to prior authorization denials and payment delays.
What this means for sellers: If you run a Medicare-certified agency, document your payer mix in detail. Break out traditional Medicare, Medicare Advantage (by plan), Medicaid, and commercial insurance separately. Buyers will want to see this breakdown, and agencies with favorable traditional Medicare percentages will command premium multiples within their size tier.
Real Transaction Comparisons: What the Data Shows
To illustrate the practical impact of the medical vs. non-medical distinction, consider these representative transaction profiles based on 2025-2026 market data:
| Profile | Agency A (Non-Medical) | Agency B (Home Health) |
|---|---|---|
| Revenue | $4,000,000 | $4,000,000 |
| Adjusted EBITDA | $600,000 (15%) | $600,000 (15%) |
| Applicable multiple | 4.5x | 7.0x |
| Enterprise value | $2,700,000 | $4,200,000 |
| Difference | $1,500,000 (56% more for the Medicare-certified agency) | |
Same revenue. Same EBITDA. Same EBITDA margin. But the Medicare-certified agency is worth $1.5 million more because of the structural advantages described above. This is not a theoretical exercise. This is the reality of the 2026 M&A market.
Which Model Is Right for Your Exit Strategy?
The answer depends on your timeline, your current operations, and your willingness to invest in transformation before going to market.
| If You Are... | Best Strategy | Timeline |
|---|---|---|
| Non-medical, selling within 12 months | Maximize within non-medical: payer diversification, management depth, EBITDA optimization | 6-12 months |
| Non-medical, selling in 2-3 years | Consider adding Medicare certification to become hybrid | 12-18 months for certification |
| Medicare home health, selling within 12 months | Optimize payer mix (reduce MA concentration), improve star ratings, document clinical outcomes | 6-12 months |
| Hybrid, selling anytime | You are already in the strongest position. Focus on integration, cross-referral metrics, and scale | Ready when you are |
Regardless of your model, the fundamentals apply: clean financials, properly calculated Adjusted EBITDA, reduced owner dependency, strong caregiver retention, and thorough due diligence preparation. These factors matter for every agency type and can move your multiple by 0.5x to 1.5x regardless of whether you are medical or non-medical.
Find Out Where Your Agency Falls
Our free Exit Readiness Scanner evaluates your agency type, revenue, payer mix, and operational maturity to estimate your valuation range and identify the specific factors that would increase your multiple. It takes four minutes and provides a personalized report with actionable recommendations.